“…Since this initial study, EV‐enriched fractions have been isolated from immortalised C2C12 cell lines at different stages of the myogenic differentiation process, as well as from primary myoblasts, myotubes and murine SM fibres (Forterre et al., 2014; Romancino et al., 2013). However, due to the lack of availability of bespoke protocols for the isolation of EVs from SM, the majority of publications to date have studied EV‐enriched fractions that also contain additional co‐isolated particles such as lipoproteins and protein aggregates (Obi et al., 2022; Rome, 2022; Rome et al., 2019). Consequently, while outcomes from previous studies have provided highly interesting observations concerning the potential functions of EVs in process such as myogenic regulation and energy metabolism (Kim et al., 2018; Shuler et al., 2020; Sork et al., 2018; Takafuji et al., 2020), they have frequently not accounted for the presence and contribution of lipoproteins and RNA binding proteins (e.g., AGO2) commonly recovered in EV preparations, which due to their overlapping diameters (low density lipoproteins: 20–200 nm) and densities (high density lipoproteins: 1.06–1.21 g/mL), can lead to inaccuracies if not depleted in the isolation protocol (Yuana et al., 2014).…”